Barbara Ryan, former Deutsche Bank senior pharma analyst, tells CNBC why investing in innovation is critical if pharmaceutical companies are to continue to make money.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT